Search research articles
Contact Us
Filters
Showing results (51-60 of 126) with videos related to
Page
of 13
Sort By:
Prevention Science : the Official Journal of the Society for Prevention Research
|
March 4, 2011
Cross-sectional study into the costs and impact on family functioning of 4-year-old children with aggressive behavior
Maartje A Raaijmakers, Jocelyne A Posthumus, Ben A van Hout, et al.
BMJ (Clinical Research Ed.)
|
July 26, 1997
Bone density and risk of hip fracture in men and women: cross sectional analysis
C E De Laet, B A van Hout, H Burger, et al.
Pharmacoeconomics
|
September 19, 2002
Costs and effectiveness of using coumarins before, during and after coronary angioplasty
Jurrien M ten Berg, Johannas C Kelder, Thys H W Plokker, et al.
Alimentary Pharmacology & Therapeutics
|
May 21, 2003
Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use
R M Klok, M J Postma, B A van Hout, et al.
Journal of Market Access & Health Policy
|
July 24, 2018
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
Emilie Clay, Aurélien Jamotte, Peter Verhamme, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 18, 1998
[Economic evaluation of cardiology; background and application]
B A van Hout, E S Goes, E W Grijseels, et al.
Clinical Therapeutics
|
May 17, 2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands
Ben A van Hout, Rogier M Klok, Jacobus R B J Brouwers, et al.
Anti-Cancer Drugs
|
May 18, 1999
An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer
M G Groener, B M van Ineveld, G Byttebier, et al.
Plos One
|
July 28, 2010
Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA
Marjan W M Wassenberg, G Ardine de Wit, Ben A van Hout, et al.
European Journal of Epidemiology
|
February 5, 2004
Prevention comes of age?
Luc G A Bonneux, Ben A van Hout, Johannes J M van Delden, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 126) with videos related to
Sort By:
Page
of 13
Prevention Science : the Official Journal of the Society for Prevention Research
|
March 4, 2011
Cross-sectional study into the costs and impact on family functioning of 4-year-old children with aggressive behavior
Maartje A Raaijmakers, Jocelyne A Posthumus, Ben A van Hout, et al.
BMJ (Clinical Research Ed.)
|
July 26, 1997
Bone density and risk of hip fracture in men and women: cross sectional analysis
C E De Laet, B A van Hout, H Burger, et al.
Pharmacoeconomics
|
September 19, 2002
Costs and effectiveness of using coumarins before, during and after coronary angioplasty
Jurrien M ten Berg, Johannas C Kelder, Thys H W Plokker, et al.
Alimentary Pharmacology & Therapeutics
|
May 21, 2003
Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use
R M Klok, M J Postma, B A van Hout, et al.
Journal of Market Access & Health Policy
|
July 24, 2018
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
Emilie Clay, Aurélien Jamotte, Peter Verhamme, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 18, 1998
[Economic evaluation of cardiology; background and application]
B A van Hout, E S Goes, E W Grijseels, et al.
Clinical Therapeutics
|
May 17, 2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands
Ben A van Hout, Rogier M Klok, Jacobus R B J Brouwers, et al.
Anti-Cancer Drugs
|
May 18, 1999
An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer
M G Groener, B M van Ineveld, G Byttebier, et al.
Plos One
|
July 28, 2010
Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA
Marjan W M Wassenberg, G Ardine de Wit, Ben A van Hout, et al.
European Journal of Epidemiology
|
February 5, 2004
Prevention comes of age?
Luc G A Bonneux, Ben A van Hout, Johannes J M van Delden, et al.
Page
of 13